Free Trial

Canopy Growth (CGC) Competitors

Canopy Growth logo
$1.10 +0.02 (+1.38%)
As of 11:06 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

CGC vs. ACB, CRON, OGI, SNDL, TLRY, VFF, STZ, MLYS, RCUS, and AVDL

Should you be buying Canopy Growth stock or one of its competitors? The main competitors of Canopy Growth include Aurora Cannabis (ACB), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), Tilray Brands (TLRY), Village Farms International (VFF), Constellation Brands (STZ), Mineralys Therapeutics (MLYS), Arcus Biosciences (RCUS), and Avadel Pharmaceuticals (AVDL).

Canopy Growth vs. Its Competitors

Canopy Growth (NASDAQ:CGC) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, media sentiment, institutional ownership, valuation, profitability and risk.

Canopy Growth has a beta of 0.73, meaning that its share price is 27% less volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 1.75, meaning that its share price is 75% more volatile than the S&P 500.

In the previous week, Canopy Growth had 1 more articles in the media than Aurora Cannabis. MarketBeat recorded 6 mentions for Canopy Growth and 5 mentions for Aurora Cannabis. Canopy Growth's average media sentiment score of 0.94 beat Aurora Cannabis' score of 0.61 indicating that Canopy Growth is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Canopy Growth
3 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Aurora Cannabis
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

3.3% of Canopy Growth shares are held by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are held by institutional investors. 1.3% of Canopy Growth shares are held by insiders. Comparatively, 0.0% of Aurora Cannabis shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Canopy Growth
2 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Aurora Cannabis
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
3.67

Aurora Cannabis has higher revenue and earnings than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Canopy Growth$225.65M0.90-$429.86M-$4.04-0.27
Aurora Cannabis$343.29M0.74$1.63M$0.1140.95

Aurora Cannabis has a net margin of 1.32% compared to Canopy Growth's net margin of -195.76%. Aurora Cannabis' return on equity of 0.13% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Canopy Growth-195.76% -88.54% -40.78%
Aurora Cannabis 1.32%0.13%0.10%

Summary

Aurora Cannabis beats Canopy Growth on 12 of the 16 factors compared between the two stocks.

Get Canopy Growth News Delivered to You Automatically

Sign up to receive the latest news and ratings for CGC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CGC vs. The Competition

MetricCanopy GrowthMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$203.18M$10.18B$5.56B$9.29B
Dividend YieldN/A2.09%4.23%4.03%
P/E Ratio-0.2716.9828.6319.63
Price / Sales0.9029.23433.6296.94
Price / CashN/A22.6736.0257.93
Price / Book0.583.608.175.61
Net Income-$429.86M$233.40M$3.24B$257.74M
7 Day Performance-12.30%-2.89%-0.30%-0.05%
1 Month Performance-23.79%1.61%5.37%8.22%
1 Year Performance-84.99%-19.39%26.34%13.46%

Canopy Growth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CGC
Canopy Growth
0.4043 of 5 stars
$1.11
+1.4%
N/A-84.7%$203.18M$225.65M-0.273,150Positive News
ACB
Aurora Cannabis
0.2935 of 5 stars
$4.43
-2.4%
N/A-26.3%$249.01M$246.72M40.271,130
CRON
Cronos Group
1.5795 of 5 stars
$2.04
flat
N/A-15.1%$786.79M$117.61M15.69450
OGI
Organigram Global
1.129 of 5 stars
$1.39
-2.8%
N/A-16.4%$186.18M$117.47M13.90860News Coverage
SNDL
SNDL
2.9714 of 5 stars
$1.24
-2.4%
$3.63
+192.3%
-31.4%$325.84M$927.61M-4.282,516
TLRY
Tilray Brands
1.8669 of 5 stars
$0.50
-6.6%
$1.92
+280.7%
-68.9%$506.67M$788.94M-0.482,650
VFF
Village Farms International
0.9775 of 5 stars
$1.25
-1.6%
N/A+19.4%$140.43M$336.18M-3.471,800
STZ
Constellation Brands
4.7376 of 5 stars
$170.51
-1.1%
$213.74
+25.4%
-33.4%$30.35B$10.96B-71.3410,600Analyst Revision
MLYS
Mineralys Therapeutics
2.1456 of 5 stars
$13.53
-6.9%
$32.25
+138.4%
+0.3%$881.89MN/A-3.6328News Coverage
Insider Trade
RCUS
Arcus Biosciences
2.3057 of 5 stars
$8.23
-2.8%
$21.29
+158.6%
-41.5%$871.48M$258M-1.96500
AVDL
Avadel Pharmaceuticals
2.0107 of 5 stars
$8.89
-0.4%
$18.17
+104.3%
-37.3%$860.02M$169.12M-32.9370

Related Companies and Tools


This page (NASDAQ:CGC) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners